Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 27;17(7):106767.
doi: 10.4240/wjgs.v17.i7.106767.

Proton beam therapy for esophageal cancer compared to existing treatments, including X-ray therapy and surgery

Takashi Ono  1   2 , Masashi Koto  1
Affiliations
Review

Proton beam therapy for esophageal cancer compared to existing treatments, including X-ray therapy and surgery

Takashi Ono et al. World J Gastrointest Surg. .

Abstract

Esophageal cancer is one of the most difficult cancers to treat since it is often at an advanced stage at the time of symptom presentation. For locally advanced esophageal cancer, treatment options include multidisciplinary treatment such as surgery or definitive chemoradiotherapy. Surgery has a high local control rate because it involves excision of the cancer along with the surrounding organs; however, it is still highly invasive, although advances in surgery have reduced the burden on patients. On the other hand, chemoradiotherapy may also be applicable in cases in which surgery is inoperable owing to complications or distant lymph node metastasis. However, chemoradiotherapy using X-ray irradiation can cause late toxicities, including those to the heart. Proton beam therapy is widely used to treat esophageal cancer because of its characteristics, and some comparisons between proton beam therapy and X-ray therapy or surgery have recently been reported. This review discusses the role of proton beam therapy in esophageal cancer in comparison to X-ray therapy and surgery.

Keywords: Chemoradiotherapy; Dose volume histogram; Esophageal neoplasms; Esophagectomy; Prognosis; Proton beam therapy; Quality of life; Toxicity; X-ray therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Schematic diagram of X-ray irradiation and proton beam therapy.
See this image and copyright information in PMC

References

    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–263. - PubMed
    1. Teng Y, Xia C, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Li Q, Tan N, Wang J, Chen W. Esophageal cancer global burden profiles, trends, and contributors. Cancer Biol Med. 2024;21:656–666. - PMC - PubMed
    1. He H, Chen N, Hou Y, Wang Z, Zhang Y, Zhang G, Fu J. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis. Thorac Cancer. 2020;11:1121–1128. - PMC - PubMed
    1. Keshava HB, Rosen JE, DeLuzio MR, Kim AW, Detterbeck FC, Boffa DJ. "What if I do nothing?" The natural history of operable cancer of the alimentary tract. Eur J Surg Oncol. 2017;43:788–795. - PubMed
    1. Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken NCT, Vogel A, Smyth EC ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:992–1004. - PubMed

LinkOut - more resources